Take part in research

Many autistic children perceive the sensory world around us differently. Some autistic children for example are overwhelmed by sounds. This can make everyday situations challenging. Being overly sensitive has also been linked to anxiety. This project will explore if sensory reactivity can predict later anxiety and related mental health symptoms.

To do so we will follow autistic children for two years, starting at age four. We will ask caregivers questions about their child’s anxiety level and how their child reacts to the sensory world around them. We will also observe children’s reactions towards sensory stimuli directly, such as different sounds. Understanding sensory processing and the relationship to anxiety better will help us to understand autistic children and their needs better. 

Cognitive-behavioural therapy (CBT) is an effective talking treatment for anxiety disorders, but courses are long and difficult to access. However, we have recently shown that even a single session of CBT already has an effect on anxiety. On the other hand, research has shown that a simple blood pressure medication called losartan can improve cognition and memory.

In this study, we would like to test whether combining a single-session of CBT with losartan can improve effects on anxiety, and what the underlying brain mechanisms of such an enhancement effect are. It is hoped that the knowledge gained from this study will contribute to the improvement of treatment for people who experience distressing panic attacks and anxiety disorders.

We aim to compare the effectiveness of quetiapine and lithium in people with treatment resistant depression.

The study is aimed at people who are struggling with depression, who are currently taking antidepressants that don't seem to be working for them. 

After checking for eligibility, participants will be randomised to quetiapine or lithium, which they will take alongside their current antidepressant for as long as is right for them. The study would want to follow participants up for 12 months, and there will be 4 or 5 meetings throughout the year with the researcher to assess how things are going.

There is a growing body of evidence suggesting that inflammation of the brain and central nervous system is linked to multiple mental health issues, including major depressive disorder (MDD). The purpose of this study is to see if adding a course of anti-inflammatory medication (minocycline) or a placebo (sugar pill) alongside a current course of antidepressant treatment (SSRI medications) can help to reduce depressive symptoms in MDD that has not responded treatment with antidepressants alone.

STAARS is part of the British Autism Study of Infant Siblings (BASIS), a UK-wide network of researchers. Our aim is to learn more about the early development of baby brothers and sisters of children with autism and/or ADHD. We hope our studies will in the long-term help to improve diagnosis of children with autism and ADHD and make it possible to design earlier and more effective interventions.

Infant participants visit our Babylab in London to complete short screen-based tasks such as watching faces or colourful animations and take part in interactive play sessions. If you are pregnant, or have a baby between 0 - 10 months AND have an older child who has been diagnosed with autism and/or ADHD, please contact us for more information.

We are recruiting people with no history of mental health, and people with current depression.

The study involves three sessions. The first session takes 1-2 hours, we will do some interviews and questionnaires asking you about your mood, past experience of mental health and family history. The second and third sessions have the same structure: you will drink a drink containing either placebo/LDOPA, then you will wait one hour, we will take a blood sample and you will complete some computer games.

Please email if you have any questions, we will be happy to answer them.

The Tackling Inequalities and Discrimination Experiences in health Services (TIDES) survey will investigate how discrimination experienced by both patients and healthcare practitioners may generate and perpetuate inequalities in health service use. As part of this, the TIDES team is currently conducting a survey which aims to understand how discrimination witnessed and experienced by healthcare practitioners is related to job satisfaction and mental well-being, and how this may contribute to inequalities in health service use. The results of this study will aid future policies and improvements to health services that will help both healthcare practitioners and people in the community.

We are trying to understand the genetic causes of schizophrenia-like illnesses that onset before the age of 14. We interview the family members and collect saliva for DNA from the affected child/adult and parents if possible. We also talk to the treating psychiatrist and take copies of medical records.

Autism Spectrum Condition (ASC) has highly diverse clinical presentations but also diverse possible biological causes. Research suggests that both core and co-occurring conditions might be partially due to an imbalance in two key brain molecules, glutamate and GABA. 

In this project we will measure the brain response before and after a single dose of a drug that acts in the GABA part of this system. We will use safe neuroimaging brain scans and also ask participants to perform simple tasks out of the scanner whilst recording their brain activity using a cap with sensors. 

We will ask the participants to come for 3 visits to King's College, Denmark Hill campus, London.

Research indicates that several forms of psychological therapy are effective for post-traumatic stress disorder (PTSD), but it is unclear how they should be best delivered. You are invited to participate in a study comparing two different types of internet-delivered therapy for PTSD. Both therapies involve working through a therapy programme online, with guidance from a therapist via secure messaging and telephone calls, for three months. A total of 175 patients for whom the treatment is suitable will be taking part in the study.

We are investigating the factors that may lead to the development of mental health problems, from genetics and biology to psychological and environmental factors.

Taking part is easy: it involves completing an online survey which asks about your contact details and some personal information, like your ethnicity and date of birth. There are also questions about your mental and physical health, as well as your lifestyle. It should take around 10-15 minutes to complete and all the information you provide is confidential. 

Depending on the information you provide, for example, where you live or the diagnoses you’ve received, we may contact you about arranging a one-to-one interview with one of our researchers to help us collect more detailed information about your experiences.

Lithium is an effective prophylactic drug for patients with bipolar disorder. However, it is not well tolerated, requires regular monitoring & has a narrow therapeutic index. Identifying a drug that has the same action but is better tolerated & safer would be advantageous. Lithium has a number of possible therapeutic targets but there is good evidence that lithium's inhibition of inositol monophosphatase (IMPase) is a key mechanism in its effects. In this study we propose to test ebselen, as a potential lithium-mimetic through its ability to inhibit IMPase. Ebselen has been shown in both animal and humans to lower inositol levels. The present study of ebselen is an 'add-on' treatment in patients with hypo/mania. 60 patients will be randomised to ebselen or matching placebo for 3 weeks.

Interoception is the ability to sense internal changes in the body such as heart rate. Some of our recent work has shown anxiety can be increased if there is a discrepancy between how well patients feel they can interpret bodily signals, such as their heartbeat, and how well they are actually able to do this. We have found that helping people to be more aware of their ability, and to increase their ability to interpret signals from the body helps reduce and may prevent anxiety symptoms. We will compare a new treatment, Aligning Dimensions of Interoceptive Experience (ADIE), against the current treatment in individuals with ASC (autism spectrum conditions). In a subset of participants we will use state of the art neuroimaging to investigate the brains physiological response to ADIE therapy.

14 - 21 day treatment (depending on your availability) with the antidepressant Escitalopram or Placebo tablet.

The study involves three sessions:

• Session 1 – This is an eligibility check session. We conduct a series of interviews that discuss your mood, experiences that you may or may not have had as well as some drug and alcohol use. We also do an ECG in this session to check that your heart is fine.
• Session 2 – You will do some behavioural tasks 2 out of the scanner and 3 in the MRI scanner. Two of these tasks will involve threat of shock, where you will be given random electric shocks. These shocks are uncomfortable but NOT painful. After this session you will be given the medication which will either be the drug or placebo, you will then go away for 14-21 days (depending on your availability and take the medication once a day.
• Session 3 – After the 14-21 days you will come back in and do the exact same session as session 2.

This study aims to explore the interactions between daytime preferences (do you like to wake early and go to bed early or do you prefer to sleep late and go to bed late), sleep quality, mood, feelings and experiences and decision making.  During this survey you will be invited to complete a number of questionnaires that assess your sleep patterns, quality of sleep, moods, feelings and experiences. You will also be asked to complete a simple decision making task. We aim to include up to 500 participants in this study.

We are looking for men who are currently expecting their first child or who have had their first baby within the last 12 months and are interested in participating in research concerning the experience of being a father.

RADAR-MDD aims to use wearable technology, such as smartphone sensors and fitness trackers, to measure symptoms of major depressive disorder and predict future relapse. We are recruiting people who have recently experienced depression to participate. Participants will be given a FitBit and asked to download some apps onto their smartphone: some apps will be used to collect information from sensors which are already in most modern smarpthone; other apps will be used for participants to answer questionnaires about their mood and social environment, or complete some cognitive tasks. For a maximum of 2-years, this data will provide insight into changes in physical activity, sleep, stress, mood, sociability, speech and cognitive function, which may be associated with future depressive relapse. 

Self-concept is an integral part of our self-identity and what makes us different to other people. This study is all about how we think about ourselves as individuals but also in relation to groups. Participants will need to fill some questionnaires and complete one computer task. 

The Brain Imaging in Babies study (BIBS) aims to improve understanding of how a baby's brain develops from before birth up until 3-4 years of age. We are also interested in better understanding brain development in babies who have a family history of Autism Spectrum Disorder (ASD) or Attention Deficit Hyperactivity Disorder (ADHD).

Boys (aged between 10 and 18-years) with Attention Deficit Hyperactivity Disorder (ADHD) will be trained over several sessions to improve their attention and self-control skills with a computer game and at the same time they will receive brain stimulation using transcranial direct current stimulation (tDCS). tDCS consists of a very small electrical current which will be placed over a frontal part of your brain to boost the learning effect in the computer game by giving your brain an extra “push”. tDCS has been around for more than 20 years, it is completely safe, has no side effects and is used in many other patient groups. This study will help the development of a new treatment for ADHD that is not reliant on pharmacological medication.

10 to 18 year old boys with ADHD will be trained over several sessions to enhance their brain activity in a magnetic resonance imaging (MRI) scanner by playing on a computer game with their brain activity. By seeing their brain activity directly they will be able to learn to change it. This is called Neurofeedback. Our previous pilot study showed that Neurofeedback improved all the behavioural problems ADHD children have and the attention skills as measured in attention tests. We also found that the positive effects were still observed and even better 11 months after the study and that there were no side effects of any kind. This study will be much larger and we plan to find the same positive effects. This study will help to develop a new treatment for ADHD that is not using medication.

We are interested in exploring whether improving learning about social information might be beneficial to young people and how does this relates to their well-being. Participants will be asked to complete some computer tasks on reasoning and social cognition, and questionnaires relating to well-being. Participants will then be randomly assigned to one of the two training group and complete an online training on for 14 days. The training lasts for at least 10 minutes per day. Once training is complete, participants will be asked to complete the same computer tasks and questionnaires again, followed with a follow up questionnaire 1 month later. 

Psychosis is the most common severe mental illness that affects 1% of the population. Coping with psychosis is often a challenging demand for the individual as well as for everyone close to them, including family members, relatives, partners and close friends (referred to as carers hereafter). The EFFIP (E-support for Families & Friends of Individuals affected by Psychosis) Project team comprising people with lived experience of psychosis, carers and professionals, has developed an online resource, called COPe. COPe provides information, peer support and coping strategies for their caregiving roles and promotes self-care. The current study aims to evaluate the clinical effectiveness of COPe in improving carers' wellbeing and other health related outcomes, compared to the waitlist-control.

We know that adolescence is a sensitive time and can result in raised levels of anxiety; for the majority these concerns disappear very quickly, but for a small number of individuals these concerns can negatively impact on their wellbeing and adjustment.

It has been shown that the way individuals focus their attention can contribute to anxiety symptoms. We have developed a new computerised intervention that aims to modify the way that young people focus their automatic attention and are looking for potential participants for a study testing this intervention. We are looking for young people (aged 12-18) who are experiencing high levels of anxiety.

The programme involves completing up to 12 sessions and you will be offered gift vouchers up to £110 as a thank you for your time.

We are looking for people who are experiencing persistent low mood and not taking antidepressants or undergoing psychological therapy, to take part in a study investigating how a new medication affects emotional decision making.

The study involves psychological tasks, one brain scan using functional Magnetic Resonance Imaging (fMRI) and taking medication for 7 days. You will be asked questions about your medical history to check your suitability for the study.

We are looking for people who are experiencing persistent low mood despite taking antidepressants, to take part in a study investigating how a new medication affects emotional decision making.

The study involves psychological tasks and taking medication for 7 days. You will be asked questions about your medical history to check your suitability for the study.

Mindfulness meditation has been found to be helpful for symptoms of depression, anxiety and stress. This study wants to find out if doing the same or different mindfulness meditations have a different impact on anxiety, depression and stress, as well as overall wellbeing.

This study is a 2-week online investigation, where participants will be randomly assigned to one of three groups: same meditation, different meditations, or listening to an audiobook. This is to compare the two types of meditation as well as testing whether they are better than a different relaxing activity.

After checking for eligibility, participants will be asked to access an online audio file daily for 2 weeks. They will also be asked to complete questionnaires at 1 week and 2 weeks after starting the study.

Even though self-harm is common very often people don’t seek any help. As many as half of young people are thought to deal with self-harm alone. Here at SHARE UK we want this to change. We need to learn more so that we can improve things like the support available in hospitals or in schools.

For this we need your help. If we know more about what kind of things would help people in the real world we can come up with new ideas and better support.

Everything you tell us is completely anonymous and confidential.

Once you have signed up you can answer some questions about yourself, fill out questionnaires, add to our media databank or sign up for our research register.

Everything is optional and you can tell us as much or as little as you like.

A free online toolkit has been developed to support the return to work of those who have been absent from work due to mental ill-health. The toolkit offers practical guidance, checklists, templates and advice. It has been developed with the input of employees, managers, business owners, employment lawyers and professionals working in Human Resources and Occupational Health around the UK.

The researchers, based at Kingston and Loughborough universities, are looking for individuals to complete short surveys and interviews about the toolkit. As part of the evaluation they will be asking employers and employees about their experience of returning to work.

Most individuals with depression and OCD do not respond to their first antidepressant treatment; it often takes several attempts before finding one that works.

This lack of precision means that individuals endure prolonged ineffective treatment and side effects before getting any relief.

With your help, we aim to develop a tool that will allow doctors to match the right antidepressant with the right person - helping people get better, faster.

It is an internet-based study so you can complete participation from your own home.

We are looking for both healthy adults and people with bipolar disorder, aged 18-60, to take part in our research study.

Participants will attend a health check screening to assess eligibility and suitable participants will be invited to take part in the study, which involves a baseline assessment day and two scanning days.

Participants will take a medication called JNJ-18038683 for one week and placebo for one week before each scan visit. JNJ-18038683, blocks the 5HT7 receptor and may be a promising new treatment for cognitive impairment in people with bipolar disorder. On each scanning day, participants will then have an MRI brain scan whilst completing computer tasks, complete a variety of mood questionnaires, and have another physical exam.

The aim of this study is to investigate the differences in mechanisms of action of psilocybin, the active ingredient in 'magic mushrooms', and the SSRI escitalopram for major depressive disorder.

All participants will have moderate-severe major depression and will receive two doses of psilocybin, three weeks apart. Psilocybin dosages will vary across the study. Some participants will also take escitalopram for 6 weeks (10mg for 3 weeks then 20mg for a further 3 weeks).

All participants will have their brains scanned before the first psilocybin dose and then 6 weeks later. There will be 7 study visits over the course of 3-4 months and participants will be expected to complete weekly questionnaires. There will also be a Skype interview 6 months after treatment and a few monthly questions.

Depression and anxiety are common but complex disorders, whose research needs very large sample sizes. The Genetic Links to Anxiety and Depression (GLAD) study aims to recruit >40,000 individuals. Anyone 16 or older who has experienced anxiety or depression during their lives can join this recontactable database to facilitate future research.

How can I take part?
All enrollment takes place online at our website (see below). An online animation explains the consent process with more detailed information in text format. Once you have provided consent and completed an online questionnaire you will be sent a saliva DNA sample kit to enable genetic studies.

We really hope you will join us in this important endeavour!

We are looking for participants with PERSISTENT ANXIETY AND/OR LOW MOOD to take part in our research study on the effects of antidepressant SSRIs on learning and emotional processing. It is hoped that this research will contribute to an improved understanding of depression and anxiety.

Study overview: a 14 or 21 day treatment of the antidepressant, escitalopram, or placebo, with behavioural and neuroimaging (fMRI) testing prior to and after the treatment. Some tasks will involve non-harmful electrical shocks.

We are recruiting participants for a study that allows them to track their mood using images via their smartphones during their everyday lives.

More specifically, our study involves installing an Android application and using it for at least two weeks. The application lets participants record their emotional state several times a day using images. They are able to track how their mood evolves during the week and relate it to images submitted.

This information, together with phone usage data, is periodically transmitted to UCL servers. In turn, our findings will be used to inform the design of systems for behavioural health interventions.

Lots of people who take antipsychotic medication find they experience sexual problems. Both men and women can be affected by sexual problems, which may include a lower sex drive or getting less pleasure from sex. At the moment, we don't know the best way to help people. One possible option is to change to a different medication that may cause fewer sexual problems.

The REMEDY study will compare a group of people that stay on the same antipsychotic medication to another group that changes to a different one to see if there is a difference between the two groups. We will also offer all people advice and support aimed at helping improve their sexual functioning.

This study looks at two different types of medication that are sometimes used in treatment of children with Attention Deficit Hyperactivity Disorder (ADHD). The medications we are studying are called Lisdexamfetamine and Guanfacine. We would like to find out how these two drugs acts on the brain of children and adolescents with ADHD. This is where you can help us!

This is a Magnetic Resonance Imaging (MRI) study which means that you will be asked to come to the Centre for Neuroimaging Sciences at Denmark Hill to have some brain scans. You will be asked to do some computer tasks while lying still in the scanner. We would like you to come in for four days within 3 weeks., i.e. for a screening appointment and three scans separated by a week each. We can also give you a picture of your brain!

You are being invited to take part in a study which is looking at the self-efficacy of individuals who have been discharged from hospital into the community, and their experiences of integration into their wider community.

You will be asked to complete a questionnaire designed to look at your self-efficacy, experience and how well you have integrated into the community since discharge. However, this is not a test and you should be able to reply freely and honestly. The questionnaire should take no longer than 20 minutes to complete.

We are undertaking medical research of an investigational medicine for the negative symptoms of schizophrenia, such as a loss of motivation and sociability. The study involves attending Kings College Hospital for 9 visits over a few months, and include having an MRI scan (a scanning procedure which does not involve radiation) as well as completing some computer tasks.

Cognitive training programmes and non-invasive brain stimulation techniques have each shown promise in research trials that treat symptoms of eating disorders. This study aims to investigate the feasibility of combining approach bias modification training (ABM) and transcranial direct current stimulation (tDCS) to treat symptoms of Binge Eating Disorder.

What’s involved?

• All participants will complete 3 assessment sessions across 7 weeks, comprised of an in-person visit (75 minutes) and online questionnaires to complete at home.
• Participants in the intervention groups will attend 6 sessions of combined cognitive training and tDCS across 3 weeks.

All parts of this study will be conducted at the IoPPN in Denmark Hill, except for the screening phone call.

This project aims to understand the role of the immune system, specifically cytokines, in anorexia nervosa. Our brain and behaviour are influenced by the immune system. Cytokines are important messenger molecules in the immune system. They can be measured in the blood and can tell us a lot about inflammation in the body. Research has shown that individuals with a diagnosis of anorexia nervosa tend to have elevated levels of certain cytokines in their blood.

We want to measure a range of cytokines to find out if the level of cytokines in individuals with a diagnosis of anorexia nervosa are related to certain clinical characteristics, like illness duration and symptom severity. The study will involve a screening phone call and, if you are eligible, a visit to the Institute of Psychology and King's College London (London, SE5 8AF).

This study conducted at the University of Cambridge Department of Psychiatry is looking for individuals with depression who have evidence of low-grade inflammation. Inflammation levels will be confirmed by a blood test. The study involves up to six visits/assessments.

If you are eligible, you receive one dose of an anti-inflammatory drug or placebo (dummy drug), given by an intravenous infusion (directly into the vein). In addition, taking part in the study involves completing questionnaires about your depressive symptoms, cognitive tests, and providing blood samples.

The Improving the Health of Young People (HYPE) project is an online recruitment, risk assessment, and resource platform for young people (aged 16+) aimed at improving the understanding of problems affecting young people's health, increasing their involvement in research as well as signposting to online and community health related resources. It aims to empower individuals within their neighbourhoods and communities by providing an environment to voice their opinions and contribute to a discussion on health inequalities; and work towards reducing these inequalities.

The HYPE project is looking for participants to take part in a (approximately) 30 minute online survey about their physical and mental health. Further information about the study can be found on HYPE's website (see below).

This research project is carrying out a series of studies to investigate different memory processes and how they work, and sometimes don't work, in people with anxiety and depression. They know that the way people with depression and anxiety remember things can be different to how other people remember things, and to how they themselves remember things when they are not feeling depressed and anxious. They therefore want to find out more about these processes so that we can find ways to change them in order to help people suffering from depression and anxiety to feel better. The studies look at memory for words and pictures and the way people remember personal events in their lives. A special focus of the studies is to look at memory for emotional material. They would like to invite you to take part.

In childhood, did you sometimes act in a way that was not typical for your gender?

This study is looking for participants to find out about their experiences of being gender non-conforming in childhood, how people reacted to this, and whether their  experiences had any impact on their psychological wellbeing.

The study is aiming to find out more about what factors protected or led to difficulties for participants in developing mental health difficulties.

The study will consist of an online screening survey, with selected participants taking part in a 45-90 minute interview in person at King's College, Denmark Hill or over the phone.

We are a group of psychologists at Trinity College Dublin. We are conducting a study that aims to test if we can predict depressive episodes before they happen by studying how networks of symptoms change as a person approaches the start of an episode. We are aiming to do this using patterns of Twitter use and the kind of language used in Tweets.

Participants will fill out a short questionnaire regarding their current depressive symptoms, basic demographic information (e.g. age, gender) and any depressive episodes that may have occurred within the past year. They will also be asked to download their Tweets from Twitter and then send them to us using a secure link.

Have you used the internet to find information about your therapist? Have you thought about this but not done so? Or has 'Googling' your therapist never crossed your mind?

This team of researchers would like to understand more about 'Therapist Googling', which involves intentionally or accidentally using any internet site (such as social media), to find information about your therapist.

If you are an adult who has had therapy with a Psychological Professional, they would like to hear about your experiences, regardless of whether or not you have ever 'Googled' your therapist. 

This randomised controlled feasibility study will evaluate two different types of attention training, the goal of which is to help improve eating habits in people who are overweight or have obesity. One is a food-related computerised attention training, the other is an  active mindfulness-based intervention (MBI). There will also be a waiting list control group.

The study will involve:

• a telephone screening
• assessment sessions, including questionnaires and computer tasks
• 8 training sessions (once a week) in the researcher's lab in Denmark Hill, London
• daily 10 minute sessions in the participant's home for 8 weeks
• an online follow-up questionnaire

This study is based on an attention training. This kind of attention training has been found to be beneficial for anxiety and depression and that is why researchers now want to test if it could also be helpful for women with eating disorders. The study looks into food-attention bias computerised attention training (FABCAT).

Participating in this research would involve attending 3 attention training sessions lasting for about 45 minutes and 2 assessment sessions (one before the first training and one after the last training). Assessment sessions will include 1h-MRI scan, some questionnaires and some computer tasks and will last for about 3h (including MRI scan).

All research sessions take place at Denmark Hill, London. 4 weeks after the last session, we will ask you to complete one questionnaire online.

This study run by the University of Glasgow is looking for participants to look at the relationship between brain waves and attention in schizophrenia and the effects of brain stimulation. This will help to see if cognition and brain function can improve in people with schizophrenia.

The study will involve 5 visits of around 2 hours over 2 month, including a clinical interview and brain imaging.

This research study based at King's College London is looking to evaluate a psychological therapy for improving low self-esteem and well-being in young people, who identify that prejudice, discrimination or stigma has affected their self-esteem.

The study involves participants taking part in an interview/assessment to explore the impact of low self-esteem and related experiences. It will then involve 6 weekly therapy session of psychological intervention aimed at improving low self-esteem and related experiences. The team are collecting feedback from participants about what it is like to receive the intervention, and looking at outcomes through questionnaires at multiple time points. Questionnaires will be online and take place at screening, sessions 1, 4 and 6 with a final follow-up questionnaire 2 months after finishing the intervention.

Taking part means being offered help for low self-esteem. The study team hope that this will be beneficial, but cannot guarantee this. They can send a copy of the final report when it is completed, and can give feedback on changes in questionnaire scores.

This research study led by a team at Aston University and the LPT Trust is looking at how physical healthcare can be improved for those with mental ill health. 

The research involves one semi-structured interview which will take place over the phone or in person in Leicester (if possible depending on location). The duration of this is 45-60 minutes approximately. 

This University of Oxford study is examining the relationships between sleep quality and timing, and personality traits that are associated with Borderline Personality Disorder (BPD).

Participants will need to complete a 20-25 minute online questionnaire on sleep habits and personality traits. All data collected will be anonymised and kept confidential.

This University of Derby study would like to invite women who experience difficulties with sexual self-control to complete a survey about their experiences and ways of understanding sexual behaviour.

Participants will be asked to imagine that you are writing a blog post to share your story as a sex addict. This post will be used for the purposes of the study and the full post will not be made publicly available. The amount of information that is included and the time it takes to do this will ultimately be up to the participant. 

This University of Reading study is looking to understand parents' experiences of parenting a child with obsessive compulsive symptoms/disorder (OCD), and to understand parents' views towards parents being involved in treatment for their child.

This study will involve parents completing a short screening questionnaire, to confirm they are eligible to take part in the study. This will take between 10 and 25 minutes to complete and will ask you general questions about you, your child, and your child's OCD. If parents are eligible to take part, they may be invited to take part in an interview, lasting approximately 45 minutes. This interview will ask you questions about your experiences of parenting you child, and your views towards parents being involved in treatment for children with OCD. These interviews will take place either by telephone, Skype or in person at the University of Reading or at the participant's home.

This study run by The Center for OCD and Related Disorders at New York State Psychiatric Institute and Columbia University Medical Center, USA, is looking to learn more about how cannabis substances affect people who suffer from OCD, so that they may be able to improve OCD treatments in the future. 

Participants will be required to complete an online survey about their experiences with cannabis substances. The survey will take around 20 minutes to complete. No identifying information will be collected as part of the research and all responses will be kept confidential.

This University of Manchester study aims to increase our understanding of the psychological processes that contribute to experiences of psychosis. This should inform the psychological therapies for distress related to this experience.

Participating in the research will involve completing an online survey that should take around 30 to 45 minutes to complete.

This study based at Birkbeck, University of London is looking to identify the earliest signs of autism and ADHD, allowing for the development of earlier and more effective interventions.

Participating in the study involves coming to the lab at Birkbeck in central London at three time periods: 5, 10 and 14 months into the study. The first of these visits would be from 10:30 to 13:00 over two days. The latter two would be from 10:30 to around 16:00 for one day each. All visits include regular breaks to allow your baby to rest, feed and play.

At these visits the researchers will do a number of tasks with your baby. These will include watching colourful animations that use eye-tracking technology to respond to where your baby is looking, an EEG which uses sensors to measure baby's brain activity, and various interactive games with researchers. 

Further follow ups are requested when your child is two and again at three years-old to allow the team to monitor progress.